J Stebbing Selected Research

J Stebbing Research Topics

Disease

24	Neoplasms (Cancer) 01/2018 - 09/2001
20	Breast Neoplasms (Breast Cancer) 10/2019 - 08/2000
5	Infections 12/2021 - 12/2003
5	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 02/2008
3	Carcinogenesis 01/2018 - 04/2015
3	Pain (Aches) 07/2011 - 12/2006
3	Kaposi Sarcoma (Kaposi's Sarcoma) 04/2009 - 11/2003
2	COVID-19 12/2021 - 08/2020
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2016 - 09/2001
2	Colonic Neoplasms (Colon Cancer) 12/2015 - 04/2013
2	Myocardial Infarction 05/2015 - 11/2005
2	Carcinoma (Carcinomatosis) 04/2015 - 07/2014
2	Prostatic Neoplasms (Prostate Cancer) 08/2014 - 02/2012
2	Lymphoma (Lymphomas) 10/2012 - 04/2009
2	Melanoma (Melanoma, Malignant) 05/2012 - 11/2004
2	HIV Infections (HIV Infection) 01/2009 - 08/2005
2	Churg-Strauss Syndrome (Allergic Angiitis) 10/2007 - 12/2000
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 10/2007 - 12/2000
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 10/2007 - 12/2000
2	Microscopic Polyangiitis 10/2007 - 12/2000
2	Insulin Resistance 05/2006 - 11/2005
1	Heart Failure 10/2019
1	Colitis-Associated Neoplasms 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Glioblastoma (Glioblastoma Multiforme) 01/2018
1	Neutropenia 01/2016
1	Alopecia (Baldness) 01/2016
1	Rectal Neoplasms (Rectal Cancer) 12/2015
1	Cardiomyopathies (Cardiomyopathy) 05/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2015
1	Uveal melanoma 09/2014
1	Esophageal Squamous Cell Carcinoma 08/2014
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2014
1	Hepatocellular Carcinoma (Hepatoma) 10/2013

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2018 - 08/2000
4	Estrogen ReceptorsIBA 01/2017 - 09/2006
3	AntibodiesIBA 08/2020 - 10/2007
3	Trastuzumab (Herceptin)FDA Link 10/2019 - 08/2000
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 02/2012
3	Phosphotransferases (Kinase)IBA 01/2016 - 02/2014
3	AnthracyclinesIBA 05/2015 - 08/2000
3	EnzymesIBA 08/2014 - 12/2000
3	AntigensIBA 08/2014 - 11/2004
3	ImmunosorbentsIBA 08/2014 - 12/2000
3	DNA (Deoxyribonucleic Acid)IBA 10/2012 - 04/2009
2	Immunoglobulin G (IgG)IBA 12/2021 - 08/2014
2	Amino Acids FDA Link 01/2017 - 11/2013
2	MicroRNAs (MicroRNA)IBA 05/2015 - 07/2014
2	Cell-Free Nucleic AcidsIBA 04/2015 - 01/2012
2	KSR-1 protein kinaseIBA 04/2015 - 11/2013
2	Tamoxifen FDA LinkGeneric 02/2014 - 07/2013
2	Bevacizumab (Avastin)FDA Link 07/2013 - 04/2013
2	Fluorouracil (Carac)FDA LinkGeneric 04/2013 - 02/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2013 - 11/2003
2	LipidsIBA 04/2012 - 05/2006
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2007 - 12/2000
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2006 - 11/2003
2	Protease Inhibitors (Protease Inhibitor)IBA 05/2006 - 08/2005
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2005 - 11/2004
1	Immunoglobulin M (IgM)IBA 12/2021
1	CT-P6IBA 10/2019
1	Biosimilar PharmaceuticalsIBA 10/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA 01/2018
1	LigandsIBA 01/2018
1	Circular RNAIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2017
1	Estrogens (Estrogen)FDA Link 01/2017
1	Tyrosine (L-Tyrosine)FDA Link 01/2017
1	Sunitinib (Sutent)FDA Link 01/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016
1	tyrosine receptor (receptor, tyrosine)IBA 01/2016
1	Epirubicin (Ellence)FDA LinkGeneric 01/2016
1	cabozantinibIBA 01/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2015
1	Oncogene Proteins (Oncogene Protein)IBA 04/2015
1	Checkpoint Kinase 1IBA 04/2015
1	AgarIBA 04/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2014
1	Immunoglobulins (Immunoglobulin)IBA 08/2014
1	AutoantibodiesIBA 08/2014
1	Transcription Factors (Transcription Factor)IBA 08/2014
1	AdrenomedullinIBA 07/2014
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2014
1	Insulin-Like PeptidesIBA 02/2014
1	Somatomedin Receptors (Somatomedin Receptor)IBA 02/2014
1	IsotopesIBA 11/2013
1	LuciferasesIBA 11/2013
1	PhosphoproteinsIBA 11/2013
1	ClaudinsIBA 10/2013
1	Claudin-1IBA 10/2013
1	Carboplatin (JM8)FDA LinkGeneric 07/2013
1	Gemcitabine FDA Link 07/2013
1	Estrogen Receptor alphaIBA 07/2013

Therapy/Procedure

21	Therapeutics 10/2017 - 12/2003
11	Drug Therapy (Chemotherapy) 01/2016 - 01/2001
6	Highly Active Antiretroviral Therapy (HAART) 04/2009 - 05/2003
2	Immunotherapy 05/2013 - 09/2001
2	Radiotherapy 01/2001 - 01/2001
1	Adjuvant Chemotherapy 12/2015